Supplementary Table 1 from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin

Supplementary Table 1 from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplati

Supplementary Figure 1 from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin

Supplementary Figure 1 from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplati

Supplementary Figure and Table Legend from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin

Supplementary Figure and Table Legend from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplati

Supplementary Data from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin

Supplementary Data from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplati

(a) Pattern of progression of AD symptoms in terms of the score for the Mini-Mental State Examination-corrected for educational level and ethnicity at 0 to 18 months

<p><b>Copyright information:</b></p><p>Taken from "Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression"</p><p></p><p>Bioinformation 2007;1(9):363-366.</p><p>Published online 21 Mar 2007</p><p>PMCID:PMC1891715.</p><p></p> The data in the figure (mean + SD) show that the score on the MMSE-C dropped significantly faster in patients with Fast Progression AD (